{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:07:54Z","timestamp":1779246474943,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["535949855"],"award-info":[{"award-number":["535949855"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006114","name":"Saxony State Ministry of Science and Art","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006114","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.biopha.2026.119271","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T01:03:05Z","timestamp":1774486985000},"page":"119271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Regulation of bone homeostasis by denosumab and genistein in a human quadruple culture bone model identifies osteocytes as important mediators"],"prefix":"10.1016","volume":"198","author":[{"given":"Katharina","family":"Wirsig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1903-1929","authenticated-orcid":false,"given":"Anne","family":"Bernhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119271_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11914-003-0011-x","article-title":"Burden of osteoporosis and fractures","volume":"1","author":"Keen","year":"2003","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.biopha.2026.119271_bib2","unstructured":"Osteoporosis: assessing the risk of fragility fracture, National Institute for Health and Care Excellence (NICE), London, 2017. \u3008http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554920\/\u3009 (accessed September 17, 2025)."},{"key":"10.1016\/j.biopha.2026.119271_bib3","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"FREEDOM Trial, Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2026.119271_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2017.08.003","article-title":"Discontinuation of Denosumab therapy for osteoporosis: a systematic review and position statement by ECTS","volume":"105","author":"Tsourdi","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.biopha.2026.119271_bib5","article-title":"Strategies for denosumab discontinuation in postmenopausal osteoporosis","author":"Degbo\u00e9","year":"2025","journal-title":"Jt. Bone Spine"},{"key":"10.1016\/j.biopha.2026.119271_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41413-024-00362-4","article-title":"Mapping RANKL- and OPG-expressing cells in bone tissue: the bone surface cells as activators of osteoclastogenesis and promoters of the denosumab rebound effect","volume":"12","author":"El-Masri","year":"2024","journal-title":"Bone Res"},{"key":"10.1016\/j.biopha.2026.119271_bib7","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167790","article-title":"Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation","volume":"8","author":"Fu","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2026.119271_bib8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/jbmr\/zjae170","article-title":"The effects of denosumab on osteoclast precursors in postmenopausal women: a possible explanation for the overshoot phenomenon after discontinuation","volume":"40","author":"Schini","year":"2025","journal-title":"J. Bone Min. Res"},{"key":"10.1016\/j.biopha.2026.119271_bib9","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00198-018-4414-z","article-title":"Estrogen therapy for osteoporosis in the modern era","volume":"29","author":"Levin","year":"2018","journal-title":"Osteoporos. Int"},{"key":"10.1016\/j.biopha.2026.119271_bib10","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.3390\/nu13093048","article-title":"Genistein: Dual Role in Women\u2019s Health","volume":"13","author":"Yu","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2026.119271_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/toxsci\/kfh147","article-title":"Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells","volume":"80","author":"Mueller","year":"2004","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.biopha.2026.119271_bib12","doi-asserted-by":"crossref","first-page":"839","DOI":"10.7326\/0003-4819-146-12-200706190-00005","article-title":"Effects of the Phytoestrogen Genistein on Bone Metabolism in Osteopenic Postmenopausal Women","volume":"146","author":"Marini","year":"2007","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.biopha.2026.119271_bib13","doi-asserted-by":"crossref","first-page":"10639","DOI":"10.1021\/acs.jafc.0c02830","article-title":"Genistein Improves Bone Healing via Triggering Estrogen Receptor Alpha-Mediated Expressions of Osteogenesis-Associated Genes and Consequent Maturation of Osteoblasts","volume":"68","author":"Wu","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2026.119271_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12906-020-03065-5","article-title":"Genistein contributes to cell cycle progression and regulates oxidative stress in primary culture of osteoblasts along with osteoclasts attenuation","volume":"20","author":"Siddiqui","year":"2020","journal-title":"BMC Complement Med Ther."},{"key":"10.1016\/j.biopha.2026.119271_bib15","doi-asserted-by":"crossref","first-page":"10605","DOI":"10.3390\/ijms150610605","article-title":"Genistein Inhibits Osteoclastic Differentiation of RAW 264.7 Cells via Regulation of ROS Production and Scavenging","volume":"15","author":"Lee","year":"2014","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119271_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/biof.2008","article-title":"Insights into the antiosteoporotic mechanism of the soy-derived isoflavone genistein: Modulation of the Wnt\/beta-catenin signaling","volume":"50","author":"Mannino","year":"2024","journal-title":"Biofactors"},{"key":"10.1016\/j.biopha.2026.119271_bib17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bcp.2004.09.025","article-title":"The novel targets for anti-angiogenesis of genistein on human cancer cells","volume":"69","author":"Su","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119271_bib18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3892\/mmr.2023.13125","article-title":"Anti\u2011oxidation effect of Genistein in vascular endothelial cell after H2O2 stress","volume":"29","author":"Xu","year":"2024","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.biopha.2026.119271_bib19","article-title":"Vascularized in vitro bone model as 3D quadruple culture with primary human osteoblasts, osteocytes, osteoclasts and endothelial cells","volume":"34","author":"Wirsig","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biopha.2026.119271_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1515\/bmt-2018-0185","article-title":"An improved method to isolate primary human osteocytes from bone","volume":"65","author":"Bernhardt","year":"2020","journal-title":"Biomed. Tech. (Berl."},{"key":"10.1016\/j.biopha.2026.119271_bib21","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.3390\/ijms22147316","article-title":"Triple Culture of Primary Human Osteoblasts, Osteoclasts and Osteocytes as an In Vitro Bone Model","volume":"22","author":"Bernhardt","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119271_bib22","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.3390\/ijms22052451","article-title":"Influence of Cu2+ on Osteoclast Formation and Activity In Vitro","volume":"22","author":"Bernhardt","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119271_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12253-017-0362-8","article-title":"Vitro Study of the Effects of Denosumab on Giant Cell Tumor of Bone: Comparison with Zoledronic Acid","volume":"25","author":"Shibuya","year":"2019","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.biopha.2026.119271_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.archoralbio.2019.03.005","article-title":"Physiological concentrations of denosumab enhance osteogenic differentiation in human mesenchymal stem cells of the jaw bone","volume":"101","author":"Mosch","year":"2019","journal-title":"Arch. Oral. Biol."},{"key":"10.1016\/j.biopha.2026.119271_bib25","doi-asserted-by":"crossref","DOI":"10.1177\/20417314221140500","article-title":"RANKL neutralisation prevents osteoclast activation in a human in vitro ameloblastoma-bone model","volume":"13","author":"Pape","year":"2022","journal-title":"J. Tissue Eng."},{"key":"10.1016\/j.biopha.2026.119271_bib26","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/term.331","article-title":"Optimization of culture conditions for osteogenically-induced mesenchymal stem cells in \u03b2-tricalcium phosphate ceramics with large interconnected channels","volume":"5","author":"Bernhardt","year":"2011","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.biopha.2026.119271_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.22203\/eCM.v033a03","article-title":"Relevance of osteoclast-specific enzyme activities in cell-based in vitro resorption assays","volume":"33","author":"Bernhardt","year":"2017","journal-title":"Eur. Cell Mater."},{"key":"10.1016\/j.biopha.2026.119271_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00774-020-01162-6","article-title":"Osteoclast differentiation by RANKL and OPG signaling pathways","volume":"39","author":"Udagawa","year":"2021","journal-title":"J. Bone Min. Metab."},{"key":"10.1016\/j.biopha.2026.119271_bib29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s11658-025-00793-9","article-title":"Crosstalk between endothelial cells and osteoblasts stimulates ALP via Notch signaling and RANKL\/OPG ratio independently of Notch signaling in vitro","volume":"30","author":"Wirsig","year":"2025","journal-title":"Cell Mol. Biol. Lett."},{"key":"10.1016\/j.biopha.2026.119271_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.813547","article-title":"Endothelial Cells Promote Osteogenesis by Establishing a Functional and Metabolic Coupling With Human Mesenchymal Stem Cells","volume":"12","author":"Petrillo","year":"2022","journal-title":"Front Physiol."},{"key":"10.1016\/j.biopha.2026.119271_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"30","author":"Kanis","year":"2019","journal-title":"Osteoporos. Int"},{"key":"10.1016\/j.biopha.2026.119271_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11657-022-01156-z","article-title":"Real-world effectiveness of osteoporosis treatments in Germany","volume":"17","author":"O\u2019Kelly","year":"2022","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.biopha.2026.119271_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-068033","article-title":"Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials","volume":"381","author":"H\u00e4ndel","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.biopha.2026.119271_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.22203\/eCM.v033a03","article-title":"Relevance of osteoclast-specific enzyme activities in cell-based in vitro resorption assays","volume":"33","author":"Bernhardt","year":"2017","journal-title":"Eur. Cell Mater."},{"key":"10.1016\/j.biopha.2026.119271_bib35","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/jbmr\/zjaf037","article-title":"Denosumab discontinuation in the clinic: implications of rebound bone turnover and emerging strategies to prevent bone loss and fractures","volume":"40","author":"Kumar","year":"2025","journal-title":"J. Bone Min. Res"},{"key":"10.1016\/j.biopha.2026.119271_bib36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11914-022-00756-5","article-title":"Osteoclast Recycling and the Rebound Phenomenon Following Denosumab Discontinuation","volume":"20","author":"Kim","year":"2022","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.biopha.2026.119271_bib37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11657-022-01145-2","article-title":"Effect of denosumab treatment on bone mineral density and bone turnover markers in osteoporotic patients: real-life experience 2-year follow-up","volume":"17","author":"Yazan","year":"2022","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.biopha.2026.119271_bib38","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/jbmr.2024","article-title":"Femoral and vertebral strength improvements in postmenopausal women with osteoporosis treated with denosumab","volume":"29","author":"Keaveny","year":"2014","journal-title":"J. Bone Min. Res"},{"key":"10.1016\/j.biopha.2026.119271_bib39","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1210\/jc.2017-02669","article-title":"Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis","volume":"103","author":"Dempster","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2026.119271_bib40","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/jbmr.4006","article-title":"Modeling-Based Bone Formation in the Human Femoral Neck in Subjects Treated With Denosumab","volume":"35","author":"Dempster","year":"2020","journal-title":"J. Bone Min. Res"},{"key":"10.1016\/j.biopha.2026.119271_bib41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41413-018-0035-6","article-title":"RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation","volume":"6","author":"Chen","year":"2018","journal-title":"Bone Res"},{"key":"10.1016\/j.biopha.2026.119271_bib42","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1074\/jbc.M112.426080","article-title":"Stimulation of Bone Formation in Cortical Bone of Mice Treated with a Receptor Activator of Nuclear Factor-\u03baB Ligand (RANKL)-binding Peptide That Possesses Osteoclastogenesis Inhibitory Activity","volume":"288","author":"Furuya","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119271_bib43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12935-023-03190-4","article-title":"Navigating challenges: optimising methods for primary cell culture isolation","volume":"24","author":"Piwocka","year":"2024","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.biopha.2026.119271_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1640935","article-title":"Comprehensive review of macrophage models: primary cells and immortalized lines across species","volume":"16","author":"Ding","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119271_bib45","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3389\/fendo.2020.00250","article-title":"Elevated Bone Hardness Under Denosumab Treatment, With Persisting Lower Osteocyte Viability During Discontinuation","volume":"11","author":"J\u00e4hn-Rickert","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2026.119271_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025900","article-title":"Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway","volume":"6","author":"Wijenayaka","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2026.119271_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s10020-024-00957-x","article-title":"Wnt\/\u03b2-catenin signaling pathway: proteins\u2019 roles in osteoporosis and cancer diseases and the regulatory effects of natural compounds on osteoporosis","volume":"30","author":"Wang","year":"2024","journal-title":"Mol. Med"},{"key":"10.1016\/j.biopha.2026.119271_bib48","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4161\/cbt.22274","article-title":"Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid","volume":"13","author":"Misso","year":"2012","journal-title":"Cancer Biol. & Ther."},{"key":"10.1016\/j.biopha.2026.119271_bib49","first-page":"649","article-title":"Skeletal benefits of soy isoflavones: a review of the clinical trial and epidemiologic data","volume":"7","author":"Messina","year":"2004","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.biopha.2026.119271_bib50","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00198-020-05476-z","article-title":"Effects of isoflavone interventions on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials","volume":"31","author":"Sansai","year":"2020","journal-title":"Osteoporos. Int"},{"key":"10.1016\/j.biopha.2026.119271_bib51","first-page":"45","article-title":"The Therapeutic Role of Genistein in Perimenopausal and Postmenopausal Women","volume":"17","author":"Nestor","year":"2024","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"10.1016\/j.biopha.2026.119271_bib52","doi-asserted-by":"crossref","first-page":"10639","DOI":"10.1021\/acs.jafc.0c02830","article-title":"Genistein Improves Bone Healing via Triggering Estrogen Receptor Alpha-Mediated Expressions of Osteogenesis-Associated Genes and Consequent Maturation of Osteoblasts","volume":"68","author":"Wu","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2026.119271_bib53","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.7150\/ijbs.7367","article-title":"Genistein promotion of osteogenic differentiation through BMP\/SMAD5\/RUNX2 signaling","volume":"9","author":"Dai","year":"2013","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2026.119271_bib54","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/biof.2008","article-title":"Insights into the antiosteoporotic mechanism of the soy-derived isoflavone genistein: Modulation of the Wnt\/beta-catenin signaling","volume":"50","author":"Mannino","year":"2024","journal-title":"BioFactors"},{"key":"10.1016\/j.biopha.2026.119271_bib55","doi-asserted-by":"crossref","first-page":"10605","DOI":"10.3390\/ijms150610605","article-title":"Genistein Inhibits Osteoclastic Differentiation of RAW 264.7 Cells via Regulation of ROS Production and Scavenging","volume":"15","author":"Lee","year":"2014","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119271_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26031114","article-title":"Cellular and Molecular Mechanisms Modulated by Genistein in Cancer","volume":"26","author":"Naponelli","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119271_bib57","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12032-010-9770-2","article-title":"Anti-angiogenic genistein inhibits VEGF-induced endothelial cell activation by decreasing PTK activity and MAPK activation","volume":"29","author":"Yu","year":"2012","journal-title":"Med Oncol."},{"key":"10.1016\/j.biopha.2026.119271_bib58","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jnutbio.2006.08.006","article-title":"Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones","volume":"18","author":"Guo","year":"2007","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.biopha.2026.119271_bib59","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.gene.2019.03.062","article-title":"Molecular docking studies of angiogenesis target protein HIF-1\u03b1 and genistein in breast cancer","volume":"701","author":"Mukund","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.biopha.2026.119271_bib60","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/jcp.29921","article-title":"Take My Bone Away?\u201d Hypoxia and bone: A narrative review","volume":"236","author":"Hannah","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2026.119271_bib61","doi-asserted-by":"crossref","first-page":"11276","DOI":"10.1002\/jcp.27785","article-title":"Flavonoid genistein protects bone marrow sinusoidal blood vessels from damage by methotrexate therapy in rats","volume":"234","author":"Hassanshahi","year":"2019","journal-title":"J. Cell. Physiol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226003045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226003045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:50:20Z","timestamp":1779245420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226003045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":61,"alternative-id":["S0753332226003045"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119271","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of bone homeostasis by denosumab and genistein in a human quadruple culture bone model identifies osteocytes as important mediators","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119271"}}